Trial intelligence / Profile preview

Teriparatide for fracture repair in humans

2014-002154-39Phase 4Completed

Sponsor
Vinforce Institut für Osteoporoseforschung
Start
Sep 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial in osteoporosis and Osteoporotic humeral fracture comparing Teriparatide with Placebo (2 arms). Primary endpoints: Acceleration of fracture repair, Enhanced biomechanical bone quality and 1 more. Started Sep 2014; status: completed.

02

Drugs

teriparatide
03

Conditions

osteoporosisOsteoporotic humeral fracture

Beyond the preview

Go deeper on 2014-002154-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002154-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call